Nonocarbolines A-E, <i>β</i>-Carboline Antibiotics Produced by the Rare Actinobacterium <i>Nonomuraea</i> sp. from Indonesia

During the course of our ongoing screening for novel biologically active secondary metabolites, the rare Actinobacterium, <i>Nonomuraea</i> sp. 1808210CR was found to produce five unprecedented <i>β</i>-carboline derivatives, nonocarbolines A−E (<b>1−5</b>). Their...

Full description

Saved in:
Bibliographic Details
Main Authors: Gian Primahana (Author), Chandra Risdian (Author), Tjandrawati Mozef (Author), Enge Sudarman (Author), Matthias Köck (Author), Joachim Wink (Author), Marc Stadler (Author)
Format: Book
Published: MDPI AG, 2020-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_31c42cfe7f984c0aa32b7bf0a297e3a1
042 |a dc 
100 1 0 |a Gian Primahana  |e author 
700 1 0 |a Chandra Risdian  |e author 
700 1 0 |a Tjandrawati Mozef  |e author 
700 1 0 |a Enge Sudarman  |e author 
700 1 0 |a Matthias Köck  |e author 
700 1 0 |a Joachim Wink  |e author 
700 1 0 |a Marc Stadler  |e author 
245 0 0 |a Nonocarbolines A-E, <i>β</i>-Carboline Antibiotics Produced by the Rare Actinobacterium <i>Nonomuraea</i> sp. from Indonesia 
260 |b MDPI AG,   |c 2020-03-01T00:00:00Z. 
500 |a 2079-6382 
500 |a 10.3390/antibiotics9030126 
520 |a During the course of our ongoing screening for novel biologically active secondary metabolites, the rare Actinobacterium, <i>Nonomuraea</i> sp. 1808210CR was found to produce five unprecedented <i>β</i>-carboline derivatives, nonocarbolines A−E (<b>1−5</b>). Their structures were elucidated from high-resolution mass spectrometry, 1D and 2D nuclear magnetic resonance spectroscopy, and the absolute configuration of <b>4</b> was determined by using the modified Mosher method. Nonocarboline B (<b>2</b>) displayed moderate antifungal activity against <i>Mucor hiemalis</i>, while nonocarboline D (<b>4</b>) exhibited significant cytotoxic activity against the human lung carcinoma cell line A-549 with the IC<sub>50</sub> value of 1.7 µM. 
546 |a EN 
690 |a <i>nonomuraea</i> sp. 1808210 cr 
690 |a rare actinobacteria 
690 |a secondary metabolite 
690 |a <i>β</i>-carbolines 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 9, Iss 3, p 126 (2020) 
787 0 |n https://www.mdpi.com/2079-6382/9/3/126 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/31c42cfe7f984c0aa32b7bf0a297e3a1  |z Connect to this object online.